Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Subir Roy: An affordable ride
Subir Roy / New Delhi November 27, 2009, 0:31 IST

Mahindra Satyam to expand Malaysia operations
Mahindra Satyam, the new brand identity of Satyam Computer Services, has embarked on international expansion and as part of this, is expanding its global solution centre (GSC) operations at its 15-acre campus in Cyberjaya, Malaysia.

News of the day

IPOs in 4 group firms possible: ICICI
ICICI Bank on Friday said it could make initial public offerings (IPO) in four subsidiaries or sell stake in its insurance ventures after the sectoral foreign direct investment (FDI) limit was raised.
Online Business

Ranbaxy to sell Neronox in India

Ranbaxy Laboratories has entered into a licensing agreement with South Korean firm Medy-Tox Inc for selling its cosmetic product, Neuronox, in India. - Orchid gets USFDA nod for injection, gets 6-mth exclusivity - Glenmark raises Rs 413 cr through QIP - Suven Life gets two more US patents for NCEs - SC issues notices to Centre, others on Novartis petition - Road to recovery: Gujarat"s pharma share rises to 30% - Aurobindo Pharma receives Swissmedic approval The company in a statement to the Bombay Stock Exchange said, it will launch Medy-Tox"s anti-ageing medicine Neuronox in India to boost its presence in the dermatological segment. Commenting on the development Sanjeev Dani, Sr Vice President and Regional Director, Ranbaxy, said, “Neuronox comes as a welcome alternative to dermatologists in India and we aim to make botulinum toxin therapy more accessible and affordable to people in the country.” Ranbaxy scrip was trading at Rs 358, up 0.83 per cent on the Bombay Stock Exchange.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009